期刊文献+

Bi_(2)O_(3)/ZnO nanocomposite:Synthesis,characterizations and its application in electrochemical detection of balofloxacin as an antibiotic drug 被引量:3

下载PDF
导出
摘要 In the present work,a chemically modified electrode has been fabricated utilizing Bi_(2)O_(3)/ZnO nanocomposite.The nanocomposite was synthesized by simple sonochemical method and characterized for its structural and morphological properties by using XRD,FESEM,EDAX,HRTEM and XPS techniques.The results clearly indicated co-existence of Bi_(2)O_(3) and ZnO in the nanocomposite with chemical interaction between them.Bi_(2)O_(3)/ZnO nanocomposite based glassy carbon electrode(GCE)was utilized for sensitive voltammetric detection of an anti-biotic drug(balofloxacin).The modification amplified the electroactive surface area of the sensor,thus providing more sites for oxidation of analyte.Cyclic and square wave voltammograms revealed that Bi_(2)O_(3)/ZnO modified electrode provides excellent electrocatalytic action towards balofloxacin oxidation.The current exhibited a wide linear response in concentration range of 150e1000 nM and detection limit of 40.5 nM was attained.The modified electrode offered advantages in terms of simplicity of preparation,fair stability(RSD 1.45%),appreciable reproducibility(RSD 2.03%)and selectivity.The proposed sensor was applied for determining balofloxacin in commercial pharmaceutical formulations and blood serum samples with the mean recoveries of 99.09% and 99.5%,respectively.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2021年第1期57-67,共11页 药物分析学报(英文版)
  • 相关文献

参考文献4

二级参考文献16

  • 1糜志远,刘万忠.新氟喹诺酮类抗生素巴洛沙星研究进展[J].中国新药杂志,2005,14(9):1205-1210. 被引量:21
  • 2夏建民.抗菌新药普利沙星[J].上海医药,1996(11):24-24. 被引量:7
  • 3刘湘,周淦,谭志荣,欧阳冬生.高效液相色谱法测定人血浆中巴洛沙星浓度[J].中南药学,2006,4(4):270-272. 被引量:4
  • 4[1]Alksne L. Balofloxacin Choongwae [J]. Curr Opin Investig Drugs,2003,4: 224-229. 被引量:1
  • 5[2]Ito T, Otsuki M, Nishino T. It vitro antibacterial activity of Q-35, a new fluoroquinolone. Antimicrob Agents Chemother, 1992, 36: 1708-1714. 被引量:1
  • 6[3]lshigai M, Nakagawa T, Suzuki H, et al. Disposition of Q-35 (2):distribution after single and repeated oral administration of 14C-Q-35in rats[J]. Drug Developnnents, 1995,10: 604-616. 被引量:1
  • 7[4]Ishigai M, Nakagawa T, Iida S, et al. Disposition of Q-35(1):absorption and excretion after single administration of 14C-Q-35 in rats[J]. Drug Developments, 1995,10: 595-603. 被引量:1
  • 8[5]Ishigai M,Nakagawa T, Hiramatsu Y,et al. Disposition of Q-35(4):metabolism after single oral administration of 14 C-Q-35 in rats and dogs [J]. Drug Developments, 1995,10: 625 -636. 被引量:1
  • 9[6]Nakagawa T, Ishigai M, Kato M.Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs [J].Arzneimittelforschung, 1995,45: 719-722. 被引量:1
  • 10OSAMU K, TOSHIHIKO U, HIROYUK M, et al. Comparative study of pharrnacokinetics of two new fluoroquinolones, Balofloxacin and Grepafloxacin, in elderly subjects[J]. Anitmicrobial Agents and Chemotherapy, 1996, 40(12) :2 824 - 2 828. 被引量:1

共引文献7

同被引文献34

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部